The MAS proto-oncogene is imprinted in human breast tissue

Genomics

Volumn 46, Issue 3, 1997, Pages 509-512

  Miller, Nicola ^a   McCann, Amanda H ^a   Connell, David ^a   Pedersen, Inge S ^a   Spiers, Valerie ^c   Gorey, Thomas ^b,d   Dervan, Peter A ^a,d  

^a Dept of Pathology ^*  (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF HULL   (United Kingdom)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; DNA; RNA;

ALLELE; ARTICLE; BREAST; BREAST CANCER; CHROMOSOME 6Q; DNA SEQUENCE; GENE EXPRESSION; GENOME IMPRINTING; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031573792     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.5063     Document Type: Article

References (24)

1. 1. Akoury, D. A., Seo, J-J., James, C. D., and Zaki, S. R. (1993). RT PCR detection of mRNA recovered from archival glass smears. Mod. Pathol. 6(2): 195-200.
2. 2. Barlow, D. P., Stoger, R., Herrmann, B. G., Saito, K., and Schweifer, N. (1991). The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349: 84-87.
3. 3. Bunnemann, B., Fuxe, K., Metzger, R., Mullins, J., Jackson, T. R., Hanley, M. R., and Ganten, D. (1990). Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization. Neurosci. Lett. 114: 147-153.
4. 4. Driscoll, D. J., Waters, M. F., Williams, C. A., Zori, R. T., Glenn, C. C., Avidano, K. M., and Nichols, R. D. (1992). A DNA methylation imprint, determined by the sex of the parent, distinguishes the Angleman and Prader-Willi syndromes. Genomics 13: 917-924.
5. 5. Feinberg, A. P. (1993). Genomic imprinting and gene activation in cancer. Nat. Genet. 4: 110-113.
6. 6. Giannoukakis, N., Deal, C., Paquette, J., Goodyear, C., and Polychronakos, C. (1993). Parental genomic imprinting of the human IGF-2 gene. Nat. Genet. 4: 98-101.
7. 7. Greer, C. E., Peterson, S. L., Kiviat, N. B., and Manos, M. (1991). PCR amplification from paraffin-embedded tissues. Am. J. Clin. Pathol. 95: 117-124.
8. KIP2 and its reduced expression in Wilms' tumours. Hum. Mol. Genet. 5(6): 783-788.
9. KIP2, on chromosome 11p15. Proc. Natl. Acad. Sci. USA 93: 3026-3030.
10. 10. McCann, A. H., Miller, N., O'Meara, A., Pedersen, I., Keogh, K., Gorey, T., and Dervan, P. A. (1996). Biallelic expression of the IGF2 gene in human breast disease. Hum. Mol. Genet. 5(8): 1123-1127.
11. 11. Mc Farland, K. C., Sprengel, R., Phillips, H. S., Kohler, M., Rosemblit, N., Nikolics, K., Segaloff, D. L., and Seeburg, P. H. (1989). Lutropin-choriogonadotropin receptor: An unusual member of the G protein-coupled receptor family. Science 245: 494-499.
12. 12. Metzger, R., Bader, M., Ludwig, T., Berberich, C., Bunnemann, B., and Ganten, D. (1995). Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett. 357: 27-32.
13. 13. Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P. J., and Reeve, A. E. (1993). Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362: 749-751.
14. 14. Ogawa, O., McNoe, L. A., Eccles, R., Morrison, I. M., and Reeve, A. E. (1993). Human insulin-like growth factor type I and II receptors are not imprinted. Hum. Mol. Genet. 2: 2163-2165.
15. 15. Pedone, P. V., Tirabosco, R., Cavazzana, A. O., Ungaro, P., Basso, G., Luksch, R., Carli, M., Bruni, C. B., Frunzio, R., and Riccio, A. (1994). Mono-and bi-allelic expression of insulin-like growth factor II gene in human muscle tumours. Hum. Mol. Genet. 3: 1117-1121.
16. 16. Rachmilewitz, J., Goshen, R., Ariel, I., Schneider, T., de Groot, N., and Hochberg, A. (1992). Parental imprinting of the human H19 gene. FEBS Lett. 309: 25-28.
17. 17. Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E., and Feinberg, A. P. (1993). Relaxation of imprinted genes in human cancer. Nature 362: 747-749.
18. 18. Reed, M. L., and Leff, S. E. (1992). Maternal imprinting of human SNRPN, a gene deleted in the Prader-Willi syndrome critical region. Nat. Genet. 6: 163-167 (1994). 917-924.
19. 19. Reisewijk, A. M., Schepens, M. T., Mariman, E. M., Ropers, H-H., and Kalscheurer, V. M. (1996). The MAS proto-oncogene is not imprinted in humans. Genomics 35: 380-382.
20. 20. Van't Veer, L. J., van den Berg-Bakker, L. I. A., Hermens, R. P. M. G., Deprez, R. L., and Schrier, P. I. (1988). High frequency of mas oncogene activation detected in the NIH3T3 tumourigenicity assay. Oncogene Res. 3: 247-254.
21. 21. Villar, J., and Pedersen, R. A. (1994). Parental imprinting of the Mas proto-oncogene in mouse. Nat. Genet. 8: 373-378.
22. 22. Xu, Y., Goodyear, C. G., Deal, C., and Polychronakos, C. (1993). Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem. Biophys. Res. Commun. 2: 747-754.
23. 23. Young, D., O'Neill, K., Jessell, T., and Wigler, M. (1988). Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain. Proc. Natl. Acad. Sci. USA 85: 5339-5342.
24. 24. Young, D., Waitches, G., Birchmeier, C., Fasano, O., and Wigler, M. (1986). Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 45: 711-719.